PRASUGREL HYDROCHLORIDE | A205913 | AMNEAL PHARMACEUTICALS OF NEW YORK LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ELI LILLY AND COMPANY et al v. ACCORD HEALTHCARE INC., USA et al 3 patentsANDA 205987, 205913prasugrel hydrochloride | S.D. Ind. | 2014-03-12 | Terminated 2018-05-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.2897
per ea
Lowest NADAC/Unit
$0.2857
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 65162000203PRASUGREL 10 MG TABLET | $0.2897 | EA | Generic | — | 2026-06-17 |
| 65162000103PRASUGREL 5 MG TABLET | $0.2857 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.